However, they did find a trend towards shorter TL in those with a family history of prostate cancer, which, in combination with the fact that TL appeared to have an effect on breast cancer risk in female BRCA1/2 mutation carriers [21], had driven our investigation into association of TL with prostate cancer risk in male BRCA1/2 mutation carriers. Here, BRCA1 is linked to breast carcinoma.